Int J Biol Sci 17(8):20502068 Yeh TL et al (2023) Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: a multivariate meta-analysis
GLP-1 users are defined as patients with an approved claim for at least one of the following GLP-1 medications in the prior 12 months: Mounjaro, Ozempic, Rybelsus, Saxenda, Wegovy, and Zepbound
Initially its 0.25mg once a week for four weeks
Additionally, semaglutide has been shown to be safe for breastfeeding mothers, allowing them to prioritize their health without concerns for their babys safety
SBP reduction was mostly mediated by weight loss (7794%) in SURPASS-1, -2 and -3, while mechanisms independent from weight loss accounted for most of the tirzepatide benefit on SBP in SURPASS-4 and -5 (57 and 73%, respectively) [77]